These effects are observed in response to both bacterial infection and stimulation with TLR agonists (e.g., Pam3CSK4, LPS, poly(I:C)), suggesting a generalized deficit in PRR-mediated NF-κB activation. Here, NFKB1 is linked to bacterial infectious disease.